| P50 | author | Jung Sun Yoo | Q55345405 |
| P2093 | author name string | Jonghwan Lee | |
| | Soonhag Kim | |
| | Sang Eun Kim | |
| | Byung Chul Lee | |
| | Byung Seok Moon | |
| | Jae Ho Jung | |
| P2860 | cites work | Projections of global mortality and burden of disease from 2002 to 2030 | Q21144688 |
| | Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q21534928 |
| | Epilogue: what do clinicians expect from imagers? | Q51943277 |
| | PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis. | Q53083524 |
| | ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree | Q72689998 |
| | Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting | Q78143346 |
| | Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis | Q79851922 |
| | Imaging and nanomedicine in inflammatory atherosclerosis | Q27002916 |
| | Progress and challenges in translating the biology of atherosclerosis | Q29619982 |
| | Imaging of angiogenesis: from microscope to clinic | Q31144032 |
| | Radiolabeled RGD uptake and alphav integrin expression is enhanced in ischemic murine hindlimbs | Q33212579 |
| | Imaging of atherosclerosis | Q33697215 |
| | Neovascularization in human atherosclerosis | Q34523545 |
| | Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events | Q36665972 |
| | Imaging of atherosclerotic cardiovascular disease | Q37089743 |
| | Imaging atherosclerotic plaque inflammation. | Q37222163 |
| | The advancing clinical impact of molecular imaging in CVD. | Q37423120 |
| | Angiogenesis as risk factor for plaque vulnerability. | Q37438350 |
| | PET and SPECT in cardiovascular molecular imaging | Q37638149 |
| | The vascular biology of atherosclerosis and imaging targets | Q37731750 |
| | Early identification of atherosclerotic disease by noninvasive imaging. | Q37741808 |
| | Radiolabelled RGD peptides for imaging and therapy | Q37990409 |
| | Imaging macrophage development and fate in atherosclerosis and myocardial infarction | Q38064660 |
| | Mechanisms of acute coronary syndromes and their implications for therapy | Q38108628 |
| | Coronary anatomy to predict physiology: fundamental limits | Q38138950 |
| | Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies. | Q38175375 |
| | Advances in the understanding of plaque composition and treatment options: year in review | Q38192382 |
| | Pathology of human plaque vulnerability: mechanisms and consequences of intraplaque haemorrhages | Q38204133 |
| | Imaging of the vasa vasorum | Q40067373 |
| | In vitro and in vivo evaluation of a novel 99mTc(CO)3-pyrazolyl conjugate of cyclo-(Arg-Gly-Asp-d-Tyr-Lys). | Q40156559 |
| | Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe | Q44074481 |
| | Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles | Q44616397 |
| | Ligands for mapping alphavbeta3-integrin expression in vivo. | Q45986254 |
| | Feasibility and kinetic characteristics of (68)Ga-NOTA-RGD PET for in vivo atherosclerosis imaging | Q47851250 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 11752 | |
| P577 | publication date | 2015-06-30 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | SPECT/CT Imaging of High-Risk Atherosclerotic Plaques using Integrin-Binding RGD Dimer Peptides | |
| P478 | volume | 5 | |